Amgen
AMGN
1,605 hedge funds and large institutions have $108B invested in Amgen in 2017 Q3 according to their latest regulatory filings, with 93 funds opening new positions, 612 increasing their positions, 644 reducing their positions, and 67 closing their positions.
39% more first-time investments, than exits
New positions opened: 93 | Existing positions closed: 67
8% more capital invested
Capital invested by funds: $99.6B → $108B (+$8.12B)
5% more funds holding in top 10
Funds holding in top 10: 84 → 88 (+4)
1% more funds holding
Funds holding: 1,595 → 1,605 (+10)
0.54% more ownership
Funds ownership: 78.53% → 79.06% (+0.54%)
5% less call options, than puts
Call options by funds: $1.3B | Put options by funds: $1.36B
5% less repeat investments, than reductions
Existing positions increased: 612 | Existing positions reduced: 644
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$361M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$247M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$246M |
| 4 |
Goldman Sachs
New York
|
+$176M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$150M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$224M |
| 2 |
State Street
Boston,
Massachusetts
|
-$196M |
| 3 |
Flossbach Von Storch
Cologne,
Germany
|
-$172M |
| 4 |
D.E. Shaw & Co
New York
|
-$154M |
| 5 |
Nordea Investment Management
Stockholm,
Sweden
|
-$133M |
AMGN Hedge Fund Activity: Q3 2017 in Review
1,605 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q3 2017, worth a combined $108B — up 8.2% from $99.6B a quarter earlier.
Buyers outnumbered sellers: 93 funds opened new AMGN positions and 67 closed out — a net gain of 26 holders — while 612 added to existing stakes and 644 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $361M. The largest seller was Capital Research Global Investors, cutting an estimated $224M.
- 1,605 institutional investors held Amgen (AMGN) as of Q3 2017, up from 1,595 in Q2 2017.
- Funds reported $108B of Amgen stock for Q3 2017, up 8.2% quarter-over-quarter.
- 93 funds opened new Amgen positions in Q3 2017 and 67 closed out, a net change of +26 holders.
- The largest Amgen buyer in Q3 2017 was Fidelity Investments, an estimated $361M added.
- The largest Amgen seller in Q3 2017 was Capital Research Global Investors, an estimated $224M sold.
Based on aggregated 13F filings for Q3 2017.